Stereotactic body radiotherapy (SBRT) versus high dose rate (HDR) brachytherapy (BT) boost for high-risk (HR) prostate cancer.

被引:1
|
作者
Gonzalez-Motta, Alejandro
Roach, Mack
机构
[1] Inst Nacl Canc, Bogota, Colombia
[2] Univ Calif San Francisco, San Francisco, CA USA
关键词
D O I
10.1200/JCO.2018.36.6_suppl.12
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
12
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Stereotactic Body Radiotherapy (SBRT) Boost to Mimic High-Dose Rate (HDR) Brachytherapy Boost for Intermediate Risk Prostate Cancer: A Phase 1 Study
    Al-Hanaqta, M.
    Loblaw, D. A.
    Chu, W.
    Ravi, A.
    Chiang, A. S., Jr.
    Jain, S.
    Chung, H. T.
    Vesprini, D.
    Morton, G.
    Deabreu, A.
    Mamedov, A.
    Zhang, L.
    Erler, D.
    Cheung, P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S208 - S208
  • [2] Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa)
    Peyraga, G.
    Lizee, T.
    Khalifa, J.
    Blais, E.
    Mauriange-Turpin, G.
    Supiot, S.
    Krhili, S.
    Tremolieres, P.
    Graff-Cailleaud, P.
    [J]. CANCER RADIOTHERAPIE, 2021, 25 (04): : 400 - 409
  • [3] A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer
    Novikov, Sergey Nikolaevich
    Novikov, Roman Vladimirovich
    Merezhko, Yurii Olegovich
    Gotovchikova, Mariya Yurevna
    Ilin, Nikolai Dmitrievich
    Melnik, Yulia Sergeevna
    Kanaev, Sergey Vasilevich
    [J]. RADIATION ONCOLOGY JOURNAL, 2022, 40 (03): : 200 - 207
  • [4] A RANDOMIZED PHASE II TRIAL OF PROSTATE BOOST IRRADIATION WITH STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN HIGH-RISK PROSTATE CANCER. THE PBS TRIAL
    Douvi, Georgia
    Isfahanian, Naghmeh
    Lukka, Himanshu
    IanDayes
    Quan, Kimmen
    Schnarr, Kara Lynne
    Goldberg, Mira
    Wright, Jim
    Hallock, Abhirami
    Ishkanian, Adrian
    Cuthbert, David
    Swaminath, Anand
    Chow, Tom
    Diamond, Kevin
    Cutz, Jean-Claude
    Kavsak, Peter
    Thabane, Lehana
    Tsakiridis, Theodoros
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S87 - S88
  • [5] Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
    Ma, Ting Martin
    Lilleby, Oscar
    Lilleby, Wolfgang A.
    Kishan, Amar U.
    [J]. CANCERS, 2020, 12 (12) : 1 - 20
  • [6] Stereotactic Body Radiation Therapy (SBRT) Boost to Mimic High-Dose-Rate (HDR) Brachytherapy for Intermediate-Risk Prostate Cancer: A Phase 1 Study
    Chiang, A. S.
    Loblaw, D.
    Chu, W.
    Jain, S.
    Erler, D.
    Ravi, A.
    Davidson, M.
    Korol, R.
    Chung, H.
    Vesprini, D.
    Morton, G.
    Cheung, P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S432 - S432
  • [7] Results of high dose rate (HDR) brachytherapy boost for prostate cancer
    Kelly, D
    Flynn, J
    Brookover, W
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S18 - S18
  • [8] The Journey of Radiotherapy Dose Escalation in High Risk Prostate Cancer; Conventional Dose Escalation to Stereotactic Body Radiotherapy (SBRT) Boost Treatments
    Mesci, Aruz
    Isfahanian, Naghmeh
    Dayes, Ian
    Lukka, Himu
    Tsakiridis, Theodoros
    [J]. CLINICAL GENITOURINARY CANCER, 2022, 20 (01) : E25 - E38
  • [9] High dose rate (HDR) brachytherapy boost for prostate cancer gives high control rate
    Flynn, J. P.
    Kelly, D. A.
    Brookover, T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S323 - S324
  • [10] A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate
    Fischer-Valuck, Benjamin W.
    Gay, Hiram A.
    Patel, Sagar
    Baumann, Brian C.
    Michalski, Jeff M.
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9